文献速递心脏核医学

基于深度学习的衰减校正在SPECT心肌灌注显像中的多中心、多厂商验证:来自国际flurpiridaz-301试验的数据

Multi-center, multi-vendor validation of deep learning-based attenuation correction in SPECT MPI: data from the international flurpiridaz-301 trial.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2022-11-19

在74个国际中心进行的flurpiridaz 3期诊断试验中,722例患者可评估SPECT和侵入性冠状动脉造影。以总灌注缺损为指标,深度学习衰减校正极性图检测阻塞性冠心病的AUC为0.752(95%CI 0.711-0.792),优于非衰减校正的0.717(0.675-0.759)(p=0.016),与专家读者共识AUC 0.743(0.701-0.784)相当(p=0.913)。

要点

  • 深度学习衰减校正(DLAC)极性图检测阻塞性冠心病AUC为0.752,优于非衰减校正的0.717,p=0.016。
  • DLAC与三位专家核心实验室读者共识的AUC 0.743相当,p=0.913。
  • 非衰减校正AUC 0.717低于专家读者共识,p=0.051。

核心结论

  • 基于深度学习的衰减校正可改善SPECT心肌灌注显像检测冠心病的诊断性能,且不受SPECT相机型号或采集方案影响。

研究设计与样本

  • 研究数据来自flurpiridaz 3期多中心诊断临床试验,该试验在74个国际中心开展,纳入已知或疑似冠心病并转诊接受临床指征侵入性冠状动脉造影的患者。
  • 共755例患者中,722例(69%为男性)具有可评估的SPECT和侵入性冠状动脉造影数据用于本分析。
  • 采用受试者工作特征(ROC)分析,以总灌注缺损(TPD)作为缺损范围和严重程度的综合指标,比较DLAC极性图与NAC极性图检测阻塞性冠心病的效能,并与三位专家核心实验室读者的视觉评分进行比较。
  • 阻塞性冠心病由核心实验室通过定量冠状动脉造影定义。

主要发现

  • DLAC检测每例患者阻塞性冠心病的AUC为0.752(95%CI 0.711-0.792),NAC为0.717(0.675-0.759),DLAC较NAC显著改善(p=0.016)。
  • 与专家读者共识AUC 0.743(0.701-0.784)相比,DLAC与之相当(p=0.913)。
  • NAC与专家读者共识相比表现较差,p=0.051。

局限性

  • 原文指出,该深度学习方法能否推广到其他具有不同扫描仪型号和采集方案的机构尚不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although SPECT myocardial perfusion imaging (MPI) is susceptible to artifacts from soft tissue attenuation, most scans are performed without attenuation correction. Deep learning-based attenuation corrected (DLAC) polar maps improved diagnostic accuracy for detection of coronary artery disease (CAD) beyond non-attenuation-corrected (NAC) polar maps in a large single center study. However, the generalizability of this approach to other institutions with different scanner models and protocols is uncertain. In this study, we evaluated the diagnostic performance of DLAC compared to NAC for detection of CAD as defined by invasive coronary angiography (ICA) in a large multi-center trial. METHODS: During the phase 3 flurpiridaz multi-center diagnostic clinical trial, conducted over 74 international sites, patients with known or suspected CAD who were referred for a clinically indicated ICA were enrolled. Using receiver operating characteristic (ROC) analysis, we evaluated the detectability of obstructive CAD, defined by quantitative coronary angiography by a core laboratory, using total perfusion deficit (TPD) as an integrated measure of defect extent and severity on DLAC polar maps compared to NAC polar maps. This was also compared against the visual scoring of three expert core lab readers. RESULTS: Out of 755 patients, 722 (69% male) had evaluable SPECT and ICA for this study. ROC analysis demonstrated significant improvement in detecting per-patient obstructive CAD with DLAC over NAC with area under the curve (AUC) of 0.752 (95% CI: 0.711-0.792) for DLAC compared to 0.717 (0.675-0.759) for NAC (p value = 0.016). Compared to the consensus of expert readers AUC = 0.743 (0.701-0.784), DLAC was comparable (p value = 0.913), whereas NAC underperformed (p value = 0.051). CONCLUSION: DL-based attenuation correction improves diagnostic performance of SPECT MPI for detecting CAD in data from a large multi-center clinical trial regardless of SPECT camera model or protocol. TRIAL REGISTRATION: A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD, ClinicalTrials.gov Identifier: NCT01347710, registered on 4 May 2011. https://clinicaltrials.gov/ct2/show/study/NCT01347710.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Hagio T, Moody JB, Poitrasson-Rivière A, et al. Multi-center, multi-vendor validation of deep learning-based attenuation correction in SPECT MPI: data from the international flurpiridaz-301 trial. Eur J Nucl Med Mol Imaging. 2022. PMID: 36401636. doi:10.1007/s00259-022-06045-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。